These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 565752)
1. Application of an economic model to the study of leprosy control costs. Lechat MF; Vellut C; Misson CB; Misson JY Int J Lepr Other Mycobact Dis; 1978; 46(1):14-24. PubMed ID: 565752 [TBL] [Abstract][Full Text] [Related]
2. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy. Velema JP; Ogbeiwi OI Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India. Zodpey SP; Ambadekar NN; Thakur A Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132 [TBL] [Abstract][Full Text] [Related]
4. Pertussis in adolescents and adults: should we vaccinate? Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232 [TBL] [Abstract][Full Text] [Related]
5. [Reform of Japan's NTP and its technical perspectives]. Mori T Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111 [TBL] [Abstract][Full Text] [Related]
6. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence. Hung HF; Chen TH Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755 [TBL] [Abstract][Full Text] [Related]
7. The impact of leprosy control on the transmission of M. leprae: is elimination being attained? Richardus JH; Habbema JD Lepr Rev; 2007 Dec; 78(4):330-7. PubMed ID: 18309706 [TBL] [Abstract][Full Text] [Related]
8. The future incidence of leprosy: a scenario analysis. Meima A; Smith WC; van Oortmarssen GJ; Richardus JH; Habbema JD Bull World Health Organ; 2004 May; 82(5):373-80. PubMed ID: 15298228 [TBL] [Abstract][Full Text] [Related]
9. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis. Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813 [TBL] [Abstract][Full Text] [Related]
10. [Where do we stand with BCG vaccination programme in Japan?]. Mori T Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330 [TBL] [Abstract][Full Text] [Related]
11. Bovine tuberculosis in badger (Meles meles) populations in southwest England: an assessment of past, present and possible future control strategies using simulation modelling. White PC; Harris S Philos Trans R Soc Lond B Biol Sci; 1995 Sep; 349(1330):415-32. PubMed ID: 8570682 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Raipur, India. Rahete NP; Zodpey SP; Kamble KM Indian J Public Health; 2007; 51(2):86-90. PubMed ID: 18240467 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales. Melegaro A; Edmunds WJ Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710 [TBL] [Abstract][Full Text] [Related]
15. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment. Altes HK; Dijkstra F; Lugnèr A; Cobelens F; Wallinga J Epidemiology; 2009 Jul; 20(4):562-8. PubMed ID: 19295437 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions. Adang E; Voordijk L; Jan van der Wilt G; Ament A Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475 [TBL] [Abstract][Full Text] [Related]
17. [Eradication of leprosy and public health. Vaccination and multidrug therapy]. Janaszek W Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583 [TBL] [Abstract][Full Text] [Related]
18. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children. Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy. Giorgi-Rossi P; Merito M; Borgia P Health Policy; 2009 Feb; 89(2):225-38. PubMed ID: 18639952 [TBL] [Abstract][Full Text] [Related]
20. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study. Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]